MedKoo Cat#: 124842 | Name: Rusfertide acetate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Rusfertide (PTG-300) is a hepcidin mimetic that regulates iron homeostasis by inhibiting ferroportin-mediated iron export from cells. In vitro studies demonstrate that rusfertide effectively reduces ferroportin expression on the surface of macrophages and enterocytes, leading to decreased iron efflux and intracellular iron accumulation. This action mimics endogenous hepcidin and results in a dose-dependent suppression of iron availability for erythropoiesis. Studies in primary human hepatocytes and cell-based models also show that rusfertide induces hepcidin-like activity without significantly altering inflammatory cytokine profiles, distinguishing it from endogenous hepcidin upregulation via inflammatory pathways

Chemical Structure

Rusfertide acetate
Rusfertide acetate
CAS#2273884-08-3 (acetate)

Theoretical Analysis

MedKoo Cat#: 124842

Name: Rusfertide acetate

CAS#: 2273884-08-3 (acetate)

Chemical Formula: C116H185N27O30S2

Exact Mass: 2500.3200

Molecular Weight: 2502.04

Elemental Analysis: C, 55.69; H, 7.45; N, 15.12; O, 19.18; S, 2.56

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Rusfertide acetate; PTG300 acetate; PTG-300 acetate; Rusfertide acetate [USAN]; L82J8IP845
IUPAC/Chemical Name
N5-(4-(9-(4-aminobutyl)-29-benzyl-23-(sec-butyl)-32-(2-carboxyethyl)-15-((1,6-diamino-1-oxohexan-2-yl)carbamoyl)-3-(3-guanidinopropyl)-6-(hydroxymethyl)-20-(1-((3-methylbutanoyl)aspartylthreonylhistidylphenylalanyl)pyrrolidine-2-carboxamido)-1,4,7,10,13,21,24,27,30,33-decaoxotetratriacontahydro-19H-pyrrolo[2,1-s][1,2]dithia[5,8,11,14,17,20,23,26,29,32]decaazacyclopentatriacontin-26-yl)butyl)-N2-palmitoylglutamine--acetic acid (1/1)
InChi Key
XDGUXPSNNIXCRG-UHFFFAOYSA-N
InChi Code
InChI=1S/C114H181N27O28S2.C2H4O2/c1-7-9-10-11-12-13-14-15-16-17-18-19-26-46-90(145)125-79(113(168)169)47-49-89(144)121-53-32-29-42-76-99(154)133-80(58-71-36-22-20-23-37-71)101(156)132-78(48-50-93(148)149)111(166)140-55-34-44-87(140)107(162)130-77(43-33-54-122-114(118)119)100(155)136-84(64-142)104(159)129-75(41-28-31-52-116)98(153)123-63-92(147)127-85(105(160)128-74(97(117)152)40-27-30-51-115)65-170-171-66-86(106(161)138-95(69(5)8-2)109(164)131-76)137-108(163)88-45-35-56-141(88)112(167)83(59-72-38-24-21-25-39-72)135-102(157)81(60-73-62-120-67-124-73)134-110(165)96(70(6)143)139-103(158)82(61-94(150)151)126-91(146)57-68(3)4;1-2(3)4/h20-25,36-39,62,67-70,74-88,95-96,142-143H,7-19,26-35,40-61,63-66,115-116H2,1-6H3,(H2,117,152)(H,120,124)(H,121,144)(H,123,153)(H,125,145)(H,126,146)(H,127,147)(H,128,160)(H,129,159)(H,130,162)(H,131,164)(H,132,156)(H,133,154)(H,134,165)(H,135,157)(H,136,155)(H,137,163)(H,138,161)(H,139,158)(H,148,149)(H,150,151)(H,168,169)(H4,118,119,122);1H3,(H,3,4)
SMILES Code
CCCCCCCCCCCCCCCC(NC(C(O)=O)CCC(NCCCCC1C(NC(CC2=CC=CC=C2)C(NC(CCC(O)=O)C(N3CCCC3C(NC(CCCNC(N)=N)C(NC(CO)C(NC(CCCCN)C(NCC(NC(C(NC(C(N)=O)CCCCN)=O)CSSCC(NC(C4CCCN4C(C(NC(C(NC(C(NC(C(NC(CC(C)C)=O)CC(O)=O)=O)C(O)C)=O)CC5=CNC=N5)=O)CC6=CC=CC=C6)=O)=O)C(NC(C(CC)C)C(N1)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O.CC(O)=O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 2,502.04 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Pemmaraju N, Kuykendall A, Kremyanskaya M, Ginzburg Y, Ritchie E, Gotlib J, Gerds A, Palmer J, Valone F, O'Connor P, Modi N, Gupta S, Hoffman R, Verstovsek S. MPN-469 Rusfertide (PTG-300) Treatment Interruption Reverses Hematological Gains and Upon Reinitiation, Restoration of Clinical Benefit Observed in Patients With Polycythemia Vera. Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S338-S339. doi: 10.1016/S2152-2650(22)01462-8. PMID: 36164011. 2: Handa S, Ginzburg Y, Hoffman R, Kremyanskaya M. Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis. Curr Opin Hematol. 2023 Mar 1;30(2):45-52. doi: 10.1097/MOH.0000000000000747. Epub 2022 Dec 29. PMID: 36728649; PMCID: PMC9908837.